Safety Alerts & Recalls

What does this mean?

Takeda UK Ltd is recalling one batch of Calcichew-D3 caplets as a precautionary measure because of traces of a non-approved substance. The manufacturers do not consider that there is any significant risk to public health. If you, or someone you know, takes Calcichew-D3 caplets please check the batch number on the pack and the corresponding expiry date. If these match the numbers above, you should return the pack to the dispensing pharmacy and they will issue a replacement. If you have any questions or concerns about the contents of this alert, then please discuss them with your pharmacist or doctor.

Takeda Recalls One Batch of Calcichew-D3 caplets due to non-approved excipient being found

Takeda UK Ltd have issued a product recall for one batch of Calcichew-D3 500mg/400 IU caplets. The affected batch – batch number 11372123, expiry date May 2019 – is being recalled due to traces of a non-approved excipient (a Patchouli-like oil) being found in the product, which has inadvertently been added to the lemon flavouring used in the manufacture of the tablets. Takeda has no reason to believe that this substance poses a significant risk to public health.

Calcichew-D3 caplets contain calcium and Vitamin D, and are prescribed for patients who are either deficient in Calcium and Vitamin D or those who need to maintain these requirements.

For more information, please visit: more information here

Source: MHRA
Publication Date: 2017-12-08
Last Updated: 2017-12-09

Visit the medication page for the following medicines:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download our free mobile app for daily design news on the go. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones